InvestorsHub Logo
Followers 5
Posts 475
Boards Moderated 0
Alias Born 09/27/2012

Re: None

Monday, 04/07/2014 8:35:27 AM

Monday, April 07, 2014 8:35:27 AM

Post# of 346685

...an equivalent antibody to Peregrine's lead immunotherapeutic antibody candidate bavituximab administered with stereotactic body radiation therapy (SBRT) showed a 100% improvement in survival and favorable tumor eradication in a model of non-small cell lung cancer (NSCLC) compared to irradiation alone. These data were presented yesterday at the 105(th) Annual Meeting of the American Association for Cancer Research (AACR) being held in San Diego, California from April 5-9, 2014.



Preclinical, but let's see if this moves the needle a bit.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News